CAC
BSX icon

Cowen and Company’s Boston Scientific BSX Stock Holding History

Cowen and Company’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-168,500
Closed -$50K – 619
2021
Q4 		$50K Buy
168,500
+7,500
+5% +$315K ﹤0.01% 441
2021
Q3 		$154K Sell
161,000
-56,100
-26% -$2.48M 0.01% 282
2021
Q2 		$205K Buy
217,100
+7,300
+3% +$307K 0.01% 276
2021
Q1 		$448K Buy
+209,800
New +$7.94M 0.03% 196

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Cowen and Company's BSX Position: Q1 2022 in Review

Cowen and Company sold out of Boston Scientific (BSX) in Q1 2022, closing a stake of 139,530 shares — an estimated $5.93M sold.

Cowen and Company first reported a position in BSX in Q1 2021 and held it in 4 quarters. The position peaked at $5.93M in Q4 2021. 905 funds tracked by Wall St. Rank hold BSX as of Q1 2022.

  • Cowen and Company reported no remaining Boston Scientific position as of Q1 2022 after selling out during the quarter.
  • Cowen and Company sold 139,530 Boston Scientific shares in Q1 2022, an estimated $5.93M.
  • Cowen and Company first reported a position in Boston Scientific in Q1 2021 and held it in 4 quarters.
  • Cowen and Company's Boston Scientific position peaked at $5.93M in Q4 2021.
  • 905 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2022.

Based on Cowen and Company's 13F filing for Q1 2022, filed 16 May 2022.